Stock Performer: Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), United Technologies Corporation (NYSE:UTX), LinkedIn Corporation (NYSE:LNKD)

Vertex Pharmaceuticals (VRTX) has submitted regulatory purposes in the U.S. and the EU seeking approval for its fully co-formulated combination of lumacaftor (400mg q12h) and Kalydeco (ivacaftor - 250mg q12h) for use in cystic fibrosis (CF) patients (≥12 years of age) who have two copies of the F508del mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) begun last trade with a price of $112.43 and throughout the trading session climbed at a high of $117.605. The day-trade ended with 5.11% to $117.29. The stock is going forward to its 52 week low with 102.02% and lagging behind from its 52 week high price with 0.35%. VRTX last month stock price volatility remained 4.14%.UTC Aerospace Systems, a division of United Technologies Corp. (UTX), newly secured an agreement valued $22M from the U.S. Air Force for the supply of upgraded wheels and brakes for their F-15 series 475 aircraft. Additionally, the contract has a follow-on option of $30M. UTC Aerospace Systems expects to commence delivery of the equipment in the summer of 2016. United Technologies Corporation (NYSE:UTX) has the market capitalization of 98.988 Billion. Shares of firm surged 0.60% to close at $108.58 with the total traded volume of 3.58 Million. The firm has current ratio of 1.20 for the most recent quarter.LinkedIn (LNKD) is set to release $1.15B convertible senior notes slated to mature in 2019. The firm is yet to decide on the interest rate or the conversion rate of the notes, but has confirmed that interest for the same will be paid to the note holders on a half-yearly basis. The company is also set to enter into privately negotiated convertible note hedge transactions to reduce the dilutive effect of the notes at the time of conversion. LinkedIn Corporation (NYSE:LNKD) stock price closed at $224.65 with the total traded volume of 3.29 Million shares. Its price to sales ratio ended at 15.10. Its market capitalization is 27.896 Billion. The stock owned by the Financial Institutions was 86.60% while by insiders was 0.50%.